Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 August 2005

Doxorubicin-induced cataract formation in rats and the inhibitory effects of hazelnut, a natural antioxidant: A histopathological study

Atilla Bayer, Cem Evereklioglu, Erkan Demirkaya, Salih Altun, Yildirim Karslioglu, Gungor Sobaci

Med Sci Monit 2005; 11(8): BR300-304 :: ID: 201126

Abstract

Background: To investigate whether hazelnut prevents doxorubicin-inducedexperimental cataract in rats. Material/Methods: Seventy-five 4-week-old male Wistar albino rats wererandomized into 5 equal groups. Beginning from 6 weeks of age, the groups were treated with intraperitonealinjections of saline solution or doxorubicin (DR) for 4 weeks. Group 1 received saline solution (0.5ml/200 g) weekly, groups 2 and 4 a cumulative dose of 6 mg/kg (1.5 mg/kg/week) of DR, and groups 3 and5 received a cumulative dose of 12 mg/kg (3 mg/kg/week) DR. All the rats were fed ad libitum with a 24%protein rodent chow. Groups 4 and 5 were additionally fed 5 g/day hazelnut. At the end of the tenth weekthe rats were sacrificed and cataract development was investigated histopathologically. The groups werestatistically compared. Results: All control lenses (group 1) were macroscopically clear. Cataractouschanges were noted in 7 eyes (47%) in group 2 and in 10 (67%) in group 3 (p=0.01). Groups 3 and 5 hadcataractous changes in 4 (27%) and 5 (33%) eyes, respectively (p=0.001). The cataract development ratiowas different between groups 2 and 4 (p=0.013), while there was no such difference between groups 3 and5 (p=0.053). Histopathological findings suggesting cataractogenesis were eosinophilic degeneration, corticallens-fiber cell swelling, and the retention of nuclei in central fibers. Conclusions: Hazelnut preventeddoxorubicin-induced cataract in low doses. Since it has no known harmful effect on healthy cells, itmay be beneficial in humans.

Keywords: Antioxidants - administration & dosage, Antioxidants - metabolism, Antioxidants - pharmacology, Antioxidants - therapeutic use, Cataract - chemically induced, Cataract - metabolism, Cataract - pathology, Cataract - prevention & control, Corylus, Diet, Doxorubicin - antagonists & inhibitors, Doxorubicin - pharmacology, Phytotherapy, Rats, Wistar, Antioxidants - therapeutic use, Cataract - prevention & control, Corylus, Diet, Doxorubicin - pharmacology, Phytotherapy, Rats, Wistar

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750